: Azhar ul Haque Sario
: The UK Cardiology Curriculum Joint Royal Colleges of Physicians Training Board (JRCPTB)
: Azhar Sario Hungary
: 9783384808769
: 1
: CHF 6.70
:
: Klinische Fächer
: English
: 200
: DRM
: PC/MAC/eReader/Tablet
: ePUB

Master the heartbeat of modern medicine with the ultimate guide to the 2026 UK Cardiology Curriculum.


 


This book is your essential roadmap to the 2026 UK Cardiology Curriculum. It breaks down the complex requirements set by the Joint Royal Colleges of Physicians Training Board. You will understand the new dual-specialty mandate for trainees. It covers General Internal Medicine alongside pure Cardiology. It explains the 'Spiral Curriculum' model clearly. You will learn about Capability-Based Progression and 'Entrustment Levels'. It details the five Advanced Themes like Intervention, Imaging, and Heart Failure. It covers key assessments like the European Exam in Core Cardiology (EECC). It explains the critical 'Critical Progression Points' you must pass. It guides you through the fierce ST4 recruitment process. It is a complete survival guide for the modern trainee.


 


Most medical textbooks only teach you the science, but this book teaches you the strategy. It fills the huge gap between clinical theory and the harsh reality of NHS training. It provides the 'inside track' on recruitment that standard guides often ignore. It explains exactly how to navigate the 2026 'Alternative Certificate' and the new 'Person Specification'. It focuses on the 'hidden curriculum' of soft skills, leadership, and professional integrity. It turns dry board regulations into actionable career advice. It gives you the competitive edge needed to secure a National Training Number. It is the mentor you wish you had.


 


Hey there, future consultant. Let's be honest-cardiology training has changed. It is not just about listening to murmurs anymore; it is about managing complex systems, leading acute takes, and navigating a training pathway that feels like an obstacle course. This book is designed to be the friendly voice in your ear through it all. We dive deep into the real stuff. You know, the things that actually keep you up at night. We talk about the 'Crisis of Time' where you have to balance being a General Physician with being a Heart Specialist.


 


We break down the scary new world of 'Unselected Medical Takes' and how to survive them without losing your mind. We don't just list the rules; we explain why they exist, from the 'Shape of Training' review to the specific demands of the 2026 recruitment cycle. Whether you are stressing about the European Exam in Core Cardiology (EECC) or trying to figure out how to get your 'Level 4 Entrustment' in pacing, this guide has your back.


 


We cover the nitty-gritty of every module, from the 'Radial First' approach in the cath lab to the 'Tricuspid Revolution' in imaging. We even tackle the tough stuff like medical ethics, legal frameworks, and how to handle the 'Duty of Candour' when things go wrong. It explores the 'Spiral Curriculum,' where you revisit themes with increasing complexity, ensuring you are ready for consultant life. It is highly creative, humanized, and packed with the specific, granular details you need to not just survive, but thrive in the 2026 landscape.


 


Legal Disclaimer: This book is independently produced by the author and is not affiliated with, endorsed by, or connected to the Joint Royal Colleges of Physicians Training Board (JRCPTB) or any other official board. All trademarks and curriculum references are used under nominative fair use for educational and descriptive purposes only.

Core Theme: Heart Failure


 

8.1 Diagnosis and Aetiology Assessment

 

The diagnosis of heart failure is a clinical puzzle. It relies on a triad: typical symptoms, specific signs, and objective evidence of structural or functional cardiac abnormality.

 

The Clinical Presentation: Symptoms and Signs

 

The classic presentation remains the breathless patient. However, the nuance lies in distinguishing cardiac breathlessness from respiratory causes.

 

Breathlessness (Dyspnoea): This is often exertional initially. As the ventricle stiffens or dilates, pressures rise in the left atrium, transmitting back to the pulmonary capillaries, causing interstitial oedema. This explains orthopnoea (breathlessness when lying flat) and Paroxysmal Nocturnal Dyspnoea (PND)—waking up gasping for air.

 

Fatigue: Often overlooked, this is a sign of"forward failure"—inadequate perfusion of skeletal muscles.

 

Oedema: Peripheral oedema is the hallmark of right-sided congestion. However, in 2026 practice, we recognize that visible oedema is a late sign. Trainees must look for"subclinical congestion" (elevated jugular venous pressure, hepatomegaly) before the ankles swell.

 

Clinical Pearl: In elderly patients,"confusion" or"reduced exercise tolerance" may be the only sign of heart failure, as they may not be active enough to experience classic exertional dyspnoea.

 

Investigating the Aetiology: The"Why"

 

Diagnosing"Heart Failure" is not a complete diagnosis; it is like diagnosing"fever." You must find the cause. The UK curriculum demands a rigorous hunt for the aetiology because it dictates the treatment.

 

Ischaemic Heart Disease (IHD): The most common cause. Previous myocardial infarctions scar the ventricle, leading to regional wall motion abnormalities (RWMA) and reduced contractility.

 

Valvular Heart Disease: Aortic stenosis (pressure overload) or mitral regurgitation (volume overload) can lead to ventricular remodeling.

 

Hypertension: Chronic high blood pressure forces the heart to pump against high resistance (afterload), causing Left Ventricular Hypertrophy (LVH). Eventually, the muscle stiffens (HFpEF) or burns out and dilates (HFrEF).

 

Dilated Cardiomyopathy (DCM): A diagnosis of exclusion, often familial or genetic.

 

Infiltrative Causes (The 2026 Focus): Amyloidosis (specifically ATTR-CM) is now diagnosed much more frequently thanks to better awareness. It presents with"red flags" like carpal tunnel syndrome, spinal stenosis, and a"sparkling" septum on echo.

 

Investigations: Characterizing the Myocardium

 

1. Natriuretic Peptides (NT-proBNP): This is the"rule-out" test. When the heart muscle stretches, it releases BNP. A normal level virtually excludes untreated heart failure. However, levels can be falsely low in obesity or falsely high in renal failure and atrial fibrillation.

 

2. Transthoracic Echocardiography (TTE): The workhorse of cardiology. It answers three key questions:

 

Structure: Are the valves working? Is the muscle thick (hypertrophy) or thin (dilation)?

 

Function: What is the Ejection Fraction (EF)? This classifies the patient into HFrEF (<40%), HFmrEF (41-49%), or HFpEF (≥50%).

 

Pressures: It estimates pulmonary artery pressures to screen for pulmonary hypertension.

 

3. Cardiac MRI (CMR): CMR is the gold standard for tissue characterization. While Echo sees the motion, MRI sees the tissue.

 

Scarring: Late Gadolinium Enhancement (LGE) can distinguish between ischaemic scarring (subendocardial) and non-ischaemic scarring (mid-wall or epicardial), which is crucial for determining aetiology in dilated cardiomyopathy.

 

Infiltration: It is definitive for diagnosing conditions like Sarcoidosis or Amyloidosis which may require specific enzyme replacement or immunosuppressive therapies.

 

Management of New-Onset Acute Heart Failure

 

When a patient presents acutely"wet" (congested), the immediate priority is decongestion.

 

Intravenous Diuretics: Furosemide is given intravenously to offload fluid. The 2026 standard involves early assessment of diuretic response (checking sodium in the urine) to escalate doses rapidly if the patient isn't responding ("diuretic resistance").

 

Vasodilators: Nitrates are used if the blood pressure is high to reduce the workload on the heart.

 

Oxygen/CPAP: Non-invasive ventilation is used if the patient is hypoxic and struggling to breathe, as it physically pushes fluid out of the alveoli.

 

8.2 Medical Optimization and Device Therapy

 

Once the patient is stable and"dry" (euvolemic), the focus shifts to prognostic medication. In 2026, the management of Heart Failure with Reduced Ejection Fraction (HFrEF) is one of the most evidence-based areas in all of medicine.

The Four Pillars of HFrEF Treatment

 

We no longer"step up" therapy slowly over months. The modern approach is the rapid sequencing or simultaneous initiation of the"Four Pillars." These drugs do not just treat symptoms; they fundamentally alter the biology of the failing heart and prolong life.

 

1. Beta-Blockers (Bisoprolol, Carvedilol, Nebivolol